An investigation for shareholders in OvaScience Inc (NASDAQ:OVAS) shares over potential securities laws violations by OvaScience Inc was announced and NASDAQ:OVAS stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 10/20/2015 --An investigation for shareholders in NASDAQ:OVAS shares over potential securities laws violations by OvaScience and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of OvaScience Inc (NASDAQ:OVAS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by OvaScience Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On March 26, 2015, OvaScience Inc announced that presentations by fertility specialists offering the Company's AUGMENTSM fertility treatment reported encouraging pregnancy rates in women who previously failed multiple cycles of in vitro fertilization (IVF). OvaScience Inc said that Clinical reports from two international IVF clinics will be featured at the Society for Reproductive Investigation (SRI) 62nd Annual Scientific Meeting.

On Mar. 28, 2015, OvaScience Inc announced that additional clinical experience of the Company's AUGMENTSM treatment demonstrated improved pregnancy rates in women who had failed three to seven prior in vitro fertilization (IVF) cycles. OvaScience Inc said that these results were reported at the Society for Reproductive Investigation (SRI) 62nd Annual Scientific Meeting being held in San Francisco, CA.

On September 28, 2015, OvaScience Inc provided an update on its corporate goal for AUGMENT treatment. OvaScience Inc announced that it does not expect to meet the 2015 goal of 1,000 AUGMENTSM treatment cycles.

Shares of OvaScience Inc (NASDAQ:OVAS) declined from over $50 per share in early 2015 to as low as $7.90 per share on September 30, 2015.

On October 19, 2015, NASDAQ:OVAS shares closed at $14.73 per share.

Those who purchased NASDAQ:OVAS shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com